← Back to Patent Explorer
US4798607A Expired / Lapsed US ⏱️ 0.0 years remaining

Process of crosslinking a polyurethane prosthesis with a haloalkylisocyante

Assignee: University of Liverpool
•
Filing: 1987-06-15
•
Granted: 1989-01-17
•
Expires: 2007-06-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process is disclosed for producing a medical prosthesis by forming the prosthesis from an uncrosslinked polyurethane and then at least partially crosslinking the polyurethane with a vaporizable halo alkylisocyanate. The haloalkylisocyanate (e.g. chloromethylisocyanate) is reacted with the uncrosslinked polyurethane at a temperature which will not degrade or soften the polyurethane, (in its uncrosslinked form) in order to crosslink the polyurethane.

Inventors

  • 👤 Ian P. Middleton
  • 👤 Jerzy Paprotny

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 06:45
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/18; C; C08; C08G; C08G18/00; C08G18/06; C08G18/08; C08G18/10; Y; Y10; Y10S; Y10S264/00; Y10S264/42; Y10S264/77; Y10S623/00; Y10S623/92; Y10S623/921; Y10S623/924; Y10S623/926

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 67 words
A process for producing a medical prosthesis, comprising forming the prosthesis from an uncross-linked polyurethane and then at least partially cross-linking the polyurethane with a cross-linking agent, by treating the prosthesis with a vaporizable halo alkyl isocyanate and reacting said isocyanate with said polyurethane by vaporizing the isocyanate at a temperature below that temperature at which the polyurethane in its uncross-linked form tends to degrade and soften.
Claim 2
Dependent Claim 67 words
A process for producing a medical prosthesis, comprising forming the prosthesis from an uncross-linked polyurethane and then at least partially cross-linking the polyurethane with a cross-linking agent, by treating the prosthesis with a vaporizable halo alkyl isocyanate and reacting said isocyanate with said polyurethane by vaporizing the isocyanate at a temperature below that temperature at which the polyurethane in its uncross-linked form tends to degrade and soften.
Claim 3
Dependent Claim 13 words
The process of claim 1 wherein the medical prosthesis is formed by molding.
Claim 4
Dependent Claim 17 words
The process of claim 2, wherein the cross-linking agent is incorporated into and molded with the polyurethane.
Claim 5
Dependent Claim 13 words
The process of claim 1, wherein the medical prosthesis is formed by dip-casting.
Claim 6
Dependent Claim 27 words
The process of claim 1, wherein the medical prosthesis is formed by electrostatically spinning a melt or solution of the polyurethane material onto an appropriately shaped former.
Claim 7
Dependent Claim 26 words
The process of claim 1, wherein the prosthesis is treated with the vaporization halo-alkyl isocyanate by immersing the prosthesis in a liquid containing the halo-alkyl isocyanate.
Claim 8
Dependent Claim 13 words
The process of claim 6, wherein the liquid comprises only the cross-linking agent.
Claim 9
Dependent Claim 27 words
The process of claim 6, wherein the liquid comprises a solution of the cross-linking agent in a solvent which will not dissolve or react with the polyurethane.
Claim 10
Dependent Claim 26 words
The process of claim 1, wherein the prosthesis is treated with the vaporizable halo-alkyl isocyanate by exposing the prosthesis to a vapor containing the halo-alkyl isocyanate.
Claim 11
Dependent Claim 12 words
The process of claim 1 wherein the halo-alkyl isocyanate is chloromethyl isocyanate.
Claim 12
Dependent Claim 15 words
The process of claim 1, wherein the cross-linking reaction takes place at approximately room temperature.
Claim 13
Dependent Claim 22 words
The process of claim 1, wherein the prosthesis is washed in water or an aqueous solution after treatment with the cross-linking agent.

References Cited (Backward Citations)

US2929800A Cited
US3545911A Cited
US3442843A Cited
US4062834A Cited
US4044404A Cited
US4131114A Cited
US4016303A Cited
US4281992A Cited
US4314948A Cited
US4381380A Cited
GB2120946A Cited
US4608416A Cited
US4623553A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-01-17 1992-07-18 1993-01-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-01-17 1996-07-18 1997-01-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-01-17 2000-07-18 2001-01-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag